Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AROA BIOSURGERY LIMITED Capital/Financing Update 2021

Jul 28, 2021

64426_rns_2021-07-28_97391f20-81d4-4fb2-80af-240110f6f095.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX ANNOUNCEMENT/MEDIA RELEASE 29 JULY 2021

==> picture [113 x 52] intentionally omitted <==

INVESTOR WEBINAR

Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘AROA’ or the ‘Company’) is pleased to announce it will hold a webinar with CEO Brian Ward and CFO James Agnew today, Thursday 29 July, at 2:00pm AEST, to discuss the outcome of the Company’s capital raising announced to the ASX this morning.

Investors can register or the webinar via the following link: https://us02web.zoom.us/webinar/register/WN_77Qs1X6tQKWKxJhP_Uxn8Q

Investors can submit questions prior to the webinar to [email protected] or do so via the Q&A function on Zoom during the session.

After registering, you will receive a confirmation email about joining the webinar. A recording will be available at the same link shortly after the conclusion of the session.

< ENDS >

Authorised on behalf of the Aroa Biosurgery Board of Directors by Brian Ward, CEO.

About Aroa Biosurgery:

Aroa Biosurgery is a soft-tissue regeneration company that develops, manufactures, sells and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Committed to ‘unlocking regenerative healing for everybody’, its products are developed from the Company’s proprietary Aroa ECM™ technology platform, a novel extracellular matrix biomaterial derived from ovine (sheep) forestomach. Aroa’s products have been used in more than four million procedures to date, with distribution into its key market of the United States by its direct sales force and its partner TELA Bio, Inc. Founded in 2008, Aroa is headquartered in Auckland, New Zealand and is listed on the Australian Securities Exchange (ASX:ARX). www.aroabio.com/

Contacts

Investor Simon Hinsley Investor Relations [email protected] + 61 401 809 653

Media Australia New Zealand Matthew Wright Piet De Jong [email protected] [email protected] +61 451 896 420 +64 21 812 766

==> picture [273 x 34] intentionally omitted <==

AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROABIO.COM